Testing effectiveness (Phase 2)Study completedNCT05304715
What this trial is testing
Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection
Who this might be right for
Clostridioides Difficile InfectionStool MicrobiomeOrgan Dysfunction Syndrome+2 more
Hellenic Institute for the Study of Sepsis 44